DR. THOMAS ROZA - UROLOOG
0505.845.496 · rovalta.com · 10/11/2026
NORMAL SITUATION
DR. THOMAS ROZA - UROLOOG
Company — Normal situation.
Financial year 2025 · Closed on 30/06/2025
Net result129,1 k €+1 713,4 %over 1 year
Gross margin184 k €+6 415,6 %over 1 year
Equity233 k €-72,2 %over 1 year
Overview
Identity
Source · BCE/KBODR. THOMAS ROZA - UROLOOG is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0505.845.496
- Legal form
- Private company with limited liability
- Contributed capital
- 18 600,00 €
- Latest accounts
- 30/06/2025
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 12 filingsTrend over 11 financial years
| 2025 | 2024 | 2024 | 2023 | 2022 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 184 k € | +6416% | -2,9 k € | -101% | 387,3 k € | +121% | 175,4 k € | +3.6% | 169,2 k € |
| EBITDA | 182,8 k € | +5005% | -3,7 k € | -101% | 385,1 k € | +122% | 173,3 k € | +3.3% | 167,8 k € |
| Operating result | 182,8 k € | +2225% | -8,6 k € | -102% | 369,4 k € | +131% | 159,6 k € | +16.5% | 137 k € |
| Net result | 129,1 k € | +1713% | -8 k € | -103% | 256,7 k € | +129% | 111,9 k € | +5.8% | 105,8 k € |
| Balance sheet | |||||||||
| Equity | 233 k € | -72.2% | 837,7 k € | +27.7% | 655,8 k € | +64.0% | 400 k € | +38.4% | 288,9 k € |
| Total assets | 240,7 k € | -76.0% | 1 M € | +20.9% | 830 k € | +43.0% | 580,5 k € | -1.9% | 592 k € |
| Cash | 105,5 k € | -52.4% | 221,5 k € | +4.5% | 212 k € | +4.6% | 202,7 k € | +0.1% | 202,5 k € |
| Debts | 7,7 k € | -95.3% | 164,1 k € | -5.8% | 174,2 k € | -3.5% | 180,5 k € | -40.4% | 303,1 k € |
Board of directors
Source · NBB, accounts to 30/06/20251 active · 1 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Thomas Bernard Roza | Liquidatorsince 26/09/2014Director01/12/2014 → 26/09/2024ended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Thomas Roza | Liquidator26/09/2024 → 2024 accountsDirector01/12/2014 → 2024 accountsManager01/12/2014 → 2019 accounts |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 27/09/2024 | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/07/2020 |
| Closing of the financial year | 30/06/2025 | 26/09/2024 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 |
| Length of the financial year | 10 months | 3 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 17/09/2025 | 17/12/2024 | 25/11/2024 | 08/01/2024 | 09/01/2023 | 20/12/2021 |
| General meeting | 31/08/2025 | 26/09/2024 | 21/09/2024 | 09/12/2023 | 10/12/2022 | 11/12/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 12 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/06/2025 | 31/08/2025 | 17/09/2025 | Dutch | |
| Micro model | 26/09/2024 | 26/09/2024 | 17/12/2024 | Dutch | |
| Micro model | 30/06/2024 | 21/09/2024 | 25/11/2024 | Dutch | |
| Micro model | 30/06/2023 | 09/12/2023 | 08/01/2024 | Dutch | |
| Micro model | 30/06/2022 | 10/12/2022 | 09/01/2023 | Dutch | |
| Micro model | 30/06/2021 | 11/12/2021 | 20/12/2021 | Dutch | |
| Micro model | 30/06/2020 | 09/10/2020 | 04/12/2020 | Dutch | |
| Micro model | 30/06/2019 | 14/12/2019 | 10/01/2020 | Dutch | |
| Micro model | 30/06/2018 | 08/12/2018 | 12/12/2018 | Dutch | |
| Micro model | 30/06/2017 | 09/12/2017 | 15/01/2018 | Dutch | |
| Abridged model | 30/06/2016 | 10/12/2016 | 11/01/2017 | Dutch | |
| Abridged model | 30/06/2015 | 12/12/2015 | 24/12/2015 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20251 active · 1 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Thomas Bernard Roza | Liquidatorsince 26/09/2014Director01/12/2014 → 26/09/2024ended |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Thomas Roza | Liquidator26/09/2024 → 2024 accountsDirector01/12/2014 → 2024 accountsManager01/12/2014 → 2019 accounts |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Name
Registered office
Annual accounts
Filings11 filings
Mandates
Thomas Bernard Roza
Thomas Roza
2014201520162017201820192020202120222023202420252026
Dr. Thomas Roza - uroloog (in vereffening)Dr. Thomas Roza - uroloog
Weygerberg 6, 2460 Kasterlee
LiquidatorDirector
DirectorManager
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Weygerberg 6, 2460 Kasterlee | accounts 2022 → 2025 | Accounts 2025 · 2025-00496780 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Dr. Thomas Roza - uroloog (in vereffening) | accounts 2024 → 2025 | Accounts 2025 · 2025-00496780 |
| Dr. Thomas Roza - uroloog | accounts 2022 → 2024 | Accounts 2024 · 2024-00607038 |
Events
- 2025Annual accounts 2025129,1 k €↑
- 2024Annual accounts 2024-8 k €↓
- 2024Name changeDr. Thomas Roza - uroloog (in vereffening)
- 2024Annual accounts 2024256,7 k €↑
- 2023Annual accounts 2023111,9 k €↑
- 2022Annual accounts 2022105,8 k €↓
- 2020Annual accounts 2020128,3 k €↑
- 2019Annual accounts 201997,4 k €↑
- 2018Annual accounts 201887,8 k €↑
- 2017Annual accounts 201783,3 k €↑
- 2016Annual accounts 201671,8 k €↓
- 2015Annual accounts 201576 k €